Vistin Pharma ASA (LTS:0RAM)
kr 27.6 0 (0%) Market Cap: 1.18 Bil Enterprise Value: 1.18 Bil PE Ratio: 19.84 PB Ratio: 3.90 GF Score: 72/100

Q2 2022 Vistin Pharma ASA Earnings Call Transcript

Aug 19, 2022 / 06:30AM GMT
Release Date Price: kr20.8
Operator

Good day, and thank you for standing by. Welcome to the Vistin Pharma Quarterly Report Q2 202 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to turn the conference over to your speaker today, Alexander Karlsen. Please go ahead.

Alexander Karlsen
Vistin Pharma ASA - CFO

Thank you, and good morning, everyone. Welcome to Vistin Pharma's Second Quarter and First Half presentation. Today's presentators will be myself, Alexander Karlsen, the CFO. And with me, I have Magnus Tolleshaug, the CCO and the interim CEO. I will now hand it over to you, Magnus.

Magnus Tolleshaug
Vistin Pharma ASA - Interim CEO, Chief Commercial Officer & Commercial Director

Thank you, Alexander. I will go through the highlights of the second quarter and year-to-date 2022 results. The second quarter ended with a revenue of NOK 69 million versus NOK 67 million in Q2 2021, which represents a 3% increase. Due to the Metformin Expansion Project, ramp-up activities,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot